Cargando…
New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy
Immunotherapy, including chimeric antigen receptor (CAR) T-cell therapy, immune checkpoint inhibitors, cancer vaccines, and dendritic cell therapy, has been incorporated as a fifth modality of modern cancer care, along with surgery, radiation, chemotherapy, and target therapy. Among them, CAR T-cell...
Autores principales: | Wu, Wan-Tai, Lin, Wen-Ying, Chen, Yi-Wei, Lin, Chun-Fu, Wang, Hsin-Hui, Wu, Szu-Hsien, Lee, Yi-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957810/ https://www.ncbi.nlm.nih.gov/pubmed/33673696 http://dx.doi.org/10.3390/ijms22052404 |
Ejemplares similares
-
Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023) -
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022) -
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010) -
Chimeric antigen receptor T cell: A cancer immunotherapy
por: Singh, Surjit, et al.
Publicado: (2022) -
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
por: Han, Ethan Q, et al.
Publicado: (2013)